Detecting the presence of Rh(D)-positive fetal red cells in the sample of an Rh(D)-negative maternal patient and need for more than 1 vial of Rh immune globulin. The test is used for screening Rh(D)-negative mothers who deliver an Rh(D)-positive infant or who are greater than 20 weeks EGA (estimated gestation age) and at risk for fetal maternal hemorrhage from a potential sensitizing event (e.g. abdominal trauma, miscarriage, external cephalic version, fetal demise).
This test is not required for routine antenatal Rh Immune Globulin administration at 28-30 weeks EGA.
This is a qualitative test only. If positive, a quantitative test (Kleihauer-Betke stain) will be reflexively performed to determine the extent of fetomaternal hemorrhage and appropriate dosage of Rh immune globulin.